pretickt

Is BG a good stock to buy?

Bunge Global S.A. · end-of-day data as of Nov 13, 2026

Bunge
BG · $19.53B
$101.65+1.7%
Nov 13, 2026 · close
$100$120SepOctNov9:3016:003 months -11.1%Nov 13 · close
▲ 7
  • PT$143.00 +40.7%
  • ConsensusBuy · 9
  • P/E vs own-19.3%
  • P/E vs sector-23.0%
  • News
  • MACD0.77
  • Sector▲ +6.0%
Neutral
  • Earnings in82d
  • P/E17.1x
  • RSI49
  • Support-6.8%
  • Resistance+2.1%
  • Off 52w high-24.6%
  • Volume0.6x
  • Bollingerupper half
  • 52w range$88–$135
  • ATR+3.0%
  • Off ATH-24.7%
  • InsidersNone in 90d
▼ 3
  • FCF yield-13.6%
  • Trendbearish
  • MAs1 of 4

Updates with the 15-min delayed price. Not a forecast or investment advice.

Is Bunge a good stock to buy?

Bunge is strong on 1 of the 5 questions about the business; weak on economics and fragility. The price is high: 17.1 times its earnings, above its 3-year median of 11.0 (Nov 13, 2026). pretickt does not say whether to buy or sell.

  1. Demand steady
  2. Advantage some edge
  3. Economics thin margins
  4. Execution delivers
  5. Fragility fragile
  6. Price expensive
DemandDo people want more of what it sells?steady

BG sales growth revenue growth

+2%a year, for the last 3 years

Bunge's sales grew 2% a year for 3 years, to $70.33B in fiscal 2025.

BG analysts' forecast revenue estimates

+33%the sales they expect next fiscal year, on the last

Analysts expect Bunge's sales to grow 33% to $93.65B in fiscal 2026 (4 analysts).

BG peers

pretickt analysis+55%its sales in 12 months, on a year before

Bunge's sales grew 55% in the 12 months to Sep 30, 2026, faster than Tyson Foods (+3%), Archer-Daniels-Midland (+1%) and Constellation Brands (-4%).

Advantage moatIs it hard to copy?some edge

BG return on capital ROIC

pretickt analysis7%earned before tax on the money invested in it

Bunge earned 7% before tax on the capital invested in it in the 12 months to Sep 30, 2026; Constellation Brands 15%, Archer-Daniels-Midland 11% and Tyson Foods 5%.

BG margin on each sale gross margin

5%left after making the product

Bunge kept 5% of each sale after making the product in the 12 months to Sep 30, 2026; its peers' median is 7%.

EconomicsDoes it make good money?thin margins

BG margin after costs profit margin

3%of sales left after running the business

Bunge's operating margin was 3% in the 12 months to Sep 30, 2026, against 3% in fiscal 2022.

BG cash generated free cash flow

-$2.66Bcash left after investing, last 12 months

Bunge burned $2.66B of cash in the 12 months to Sep 30, 2026, after its investments.

ExecutionDoes it deliver what it promises?delivers

BG earnings vs estimates

7 of 8quarters above the analysts' estimate

Bunge beat the analysts' profit estimate in 7 of its last 8 quarters, the latest on Oct 29, 2026.

BG insider selling

-$2.04Msold, net, by its executives in 12 months

Bunge's executives and directors sold a net $2.04M of shares in the 12 months to Nov 13, 2026 ($2.72M sold, $689K bought).

BG number of employees

+48%more people in a year

Bunge had 34,000 employees at the end of fiscal 2025, 48% more than a year before.

BG CEO pay

$18.95Mfor fiscal 2025, 67% of it in stock and options

Bunge paid its CEO $18.95M for fiscal 2025, 67% of it in stock and options.

Fragility risksCould something break it?fragile

BG financial health Altman Z-score

3.0Altman Z-score, safe above 3

Bunge's Altman Z-score is 3.0 (Nov 13, 2026), above 3, where the safe zone starts.

BG quality checks Piotroski score

3 of 9checks passed

Bunge passes 3 of the 9 Piotroski checks in the 12 months to Sep 30, 2026; it misses on cash from operations, return on assets, cash against profit, the current ratio, new shares and gross margin.

BG in past recessions

pretickt analysis-20%its sales in the worst one

Bunge's sales fell in 1 of the last 2 US recessions, by as much as 20% in fiscal 2009.

Price valuationIs the price reasonable?expensive

BG price vs profit P/E ratio

17.1×a year's earnings

Bunge's P/E ratio is 17.1 (Nov 13, 2026), above its 3-year median of 11.0.

BG price vs peers

pretickt analysis17.1×a year's earnings, against its peers

Investors pay 17.1 times Bunge's earnings (Nov 13, 2026), more than for Archer-Daniels-Midland (14.2) and Constellation Brands (13.1), less than for Tyson Foods (36.3).

BG analysts' target price target

+41%to their average target

Analysts' average price target for Bunge is $143, 41% above the Nov 13, 2026 close of $101.65.

What is Bunge's P/E ratio?

Bunge's P/E ratio is 17.1 (Nov 13, 2026), above its 3-year median of 11.0. Investors pay 17.1 times Bunge's earnings (Nov 13, 2026), more than for Archer-Daniels-Midland (14.2) and Constellation Brands (13.1), less than for Tyson Foods (36.3).

Is Bunge profitable?

Bunge's operating margin was 3% in the 12 months to Sep 30, 2026, against 3% in fiscal 2022. Bunge burned $2.66B of cash in the 12 months to Sep 30, 2026, after its investments.

Are insiders selling Bunge stock?

Bunge's executives and directors sold a net $2.04M of shares in the 12 months to Nov 13, 2026 ($2.72M sold, $689K bought).

How many employees does Bunge have?

Bunge had 34,000 employees at the end of fiscal 2025, 48% more than a year before.

From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.